RxDoctor Payments DataLook up a doctor →

VYNDAQEL: payments to doctors

Payments that named VYNDAQEL as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$11.8M
Providers
36,054
Transactions
159,952
Average per transaction
$74

The per-transaction average — $74 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 36,054 providers the average total is $329, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Pfizer$11,770,44599.3%
PBG Puerto RICO LLC$69,2520.6%
Pfizer Pharmaceuticals LLC$5,5500.0%
Whitehall International Inc$2,7500.0%
Pfizer Pharmaceuticals Korea Limited$220.0%
← All drugs & devices